Phenotype-specific treatment of difficult asthma in children

Paediatric Respiratory Reviews

Volumn 5, Issue 2, 2004, Pages 116-123

  Payne, Donald ^a   Bush, Andrew ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Airway inflammation; Asthma; Bronchial hyper reactivity; Corticosteroid; Eosinophil; Neutrophil; Steroid receptor

Indexed keywords

AZITHROMYCIN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CYCLOSPORIN; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; PREDNISOLONE; TERBUTALINE; TRIAMCINOLONE;

AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CHILD; CHILD CARE; CLINICAL PROTOCOL; DISEASE SEVERITY; DOSE RESPONSE; DRUG RESISTANCE; EOSINOPHIL; HUMAN; INDIVIDUALIZATION; LOEFFLER PNEUMONIA; LUNG FUNCTION; NEUTROPHIL; NON INVASIVE MEASUREMENT; PATIENT COMPLIANCE; PHENOTYPE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESPIRATORY AIRFLOW; SIDE EFFECT; TREATMENT PLANNING;

EID: 2542618298     PISSN: 15260542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prrv.2004.01.006     Document Type: Review

References (49)

1. Warner JO, Gotz M, Landau L et al. Management of asthma: a consensus statement. Arch Dis Child 1989; 64: 1065-1079.
2. Asher R. Making sense. In: Talking Sense. Bath: Pitman Medical. 1972.
3. Siersted HC, Mostgaard G, Hyldebrandt N, Hansen HS, Boldsen J, Oxhoj H. Interrelationships between diagnosed asthma, asthma-like symptoms and abnormal airway behaviour in adolescence. The Odense Schoolchild Study. Thorax 1996; 51: 503-509.
4. Bush A, Price JP. Childhood asthma syndromes. In: Gibson GJ, Geddes DM, Costabel J, Sterk P, Corrin B (eds). Respiratory Medicine, 3rd edn. Saunders, Edinburgh, 2003 pp. 1396-1420.
5. Silverman M, Wilson NM. Wheezing phenotypes in childhood. Thorax 1997; 52: 936-937.
6. Payne DN, Balfour-Lynn I, Children with difficult asthma: a practical approach. J Asthma 2001; 38: 189-203.
7. McKenzie SM, Bush A. Difficult asthma in children. Arch Dis Child 2003; 88: 168-169.
8. Gemou-Engesaeth V, Kay AB, Bush A, Corrigan CJ. Activated peripheral blood CD4 and CD8 T-lymphocytes in child asthma: correlation with eosinophilia and disease severity. Pediatr Allergy Immunol 1994; 5: 170-177.
9. Gemou-Engesaeth V, Bush A, Kay AB, Hamid Q, Corrigan C. Inhaled glucocorticoid therapy of childhood asthma is associated with reduced peripheral blood T cell activation and 'Th2-type' cytokine mRNA expression. Pediatrics 1997; 99: 695-703.
10. Payne DNR, Adcock IM, Wilson NM. Oates T, Scallan M, Bush A. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med 2001; 164: 1376-1381.
11. Barbato A, Turato G, Baraldo S et al. Airway inflammation in childhood asthma. Am J Respir Crit Care Med 2003; 168: 798-803.
12. Douwes J, Gibson P, Pekkanen J, Pearce N. Non-eosinophilic asthma: importance and possible mechanisms. Thorax 2002; 57: 643-648.
13. Leckie MJ, Ten Brinke A, Khan J et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000; 356: 2144-2148.
14. Bryan SA, O'Connor BJ, Matti S et al. Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000; 356: 2149-2153.
15. Flood-Page PT, Menzies-Gow AN, Kay AB, Robinson DS. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med 2003; 167: 199-204.
16. Crimi E, Spanevello A, Neri M et al. Dissociation between airway inflammation and airway hyperresponsiveness in alllergic asthma. Am J Respir Crit Care Med 1998; 157: 4-9.
17. Joos GF, O'Connor B, Anderson SD et al. Indirect airway challenges. Eur Respir J 2003; 21: 1050-1068.
18. Hofstra WB, Neil HJ, Duiverman EJ et al. Dose-response over time to inhaled fluticasone propionate treatment of exercise- and methacholine-induced bronchoconstriction in children with asthma. Pediatr Pulmonol 2000; 29: 415-423.
19. Wilson NM, James A, Uasuf C et al. Asthma severity and inflammation markers in children. Pediatr Allergy Immunol 2001; 12: 125-132.
20. Sont JK, Willems LN, Bel EH et al. Clinical control and histopathological outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL study group. Am J Respir Crit Care Med 1999; 159: 1043-1051.
21. Lodrup-Carlsen KC, Jaakkola JJ, Nafstad P, Carlsen KH. In utero exposure to cigarette smoking influences lung function at birth. Eur Respir J 1997; 10: 1774-1779.
22. Stick SM, Burton PR, Gurrin L, Sly PD, LeSouef PN. Effects of maternal smoking during pregnancy and a family history of asthma on respiratory function in newborn infants. Lancet 1996; 348: 1060-1064.
23. Young S, LeSouef PN, Geelhoed GC et al. The influence of a family history of asthma and parental smoking on airway responsiveness in early infancy. N Engl J Med 1991; 324: 1166-1173.
24. Payne DN, Rogers AV, Adelroth E et al. Early thickening of the reticular basement membrane in children with difficult asthma. Am J Respir Crit Care Med 2003; 167: 78-82.
25. Jenkins HA, Cool C, Szefler SJ et al. Histopathology of severe childhood asthma: a case series. Chest 2003; 124: 32-41.
26. Frey U, Makkonen K, Wellman T, Beardsmore C, Silverman M. Alterations in airway wall properties in infants with a history of wheezing disorders. Am J Respir Crit Care Med 2000; 161: 1825-1829.
27. Elliot J, Carroll N, Bosco M, McCrohan M, Robinson P. Increased airway responsiveness and decreased attachment points following in utero smoke exposure in the guinea pig. Am J Respir Crit Care Med 2001; 163: 140-144.
28. British Thoracic Society, Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Thorax 2003; 58 (Suppl. 1): i1-i94.
29. Payne DNR, Wilson NM, James A, Hablas H, Agrafioti C, Bush A. Evidence for different subgroups of difficult asthma in children. Thorax 2001; 56: 345-350.
30. Gibson RL, Emerson J, McNamara S et al. Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis. Am J Respir Crit Care Med 2003; 167: 84 1-849.
31. Redline S, Wright EC, Kattan M, Kercsmar C, Weiss K. Short term compliance with peak flow monitoring: results from a study of inner city children with asthma. Pediatr Pulmonol 1996; 21: 203-210.
32. Payne DNR, McKenzie SA, Stacey S, Misra D, Haxby E, Bush A. Safety and ethics of bronchoscopy and endobronchial biopsy in difficult asthma. Arch Dis Child 2001; 84: 423-426.
33. Payne DN, Adcock IM. Molecular mechanisms of corticosteroid actions. Paediatr Respir Rev 2001; 2: 145-150.
34. Payne DN, Hubbard M, McKenzie SA. Corticosteroid unresponsiveness in asthma: primary or acquired? Pediatr Pulmonol 1998; 25: 59-61.
35. Nimmagadda SR, Szefler SJ, Spahn JD, Surs W, Leung DYM. Allergen exposure decreases glucocorticoid receptor binding affinity and steroid responsiveness in atopic asthmatics. Am Rev Respir Crit Care Med 1997; 155: 87-93.
36. Leung D, Hamid Q, Vottero A et al. Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor beta. J Exp Med 1997; 185: 1567-1574.
37. Coren M, Rosenthal M, Bush A. The use of cyclosporin in corticosteroid dependant asthma. Arch Dis Child 1997; 77: 522-523.
38. van den Toorn LM, Overbeek SE, de Jongste JC, Leman K, Hoogsteden HC, Prins JB. Airway inflammation is present during clinical remission of atopic asthma. Am J Respir Crit Care Med 2002; 164: 2107-2113.
39. Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord I. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 2002; 346: 1699-1705.
40. Wenzel SE, Szefler SJ, Leung DYM et al. Bronchoscopic evaluation of severe asthma. Am J Respir Crit Care Med 1997; 156: 737-743.
41. Meagher LC, Cousin JM, Seckl JR et al. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol 1996; 156: 4422-4428.
42. Jaffe A, Bush A. Anti-inflammatory effects of macrolides in lung disease. Pediatr Pulmonol 2001; 31: 464-473.
43. Yasui K, Hu B, Nakazawa T et al. Theophylline accelerates human granulocyte apoptosis not via phosphodiesterase inhibition. J Clin Invest 1997; 100: 1677-1684.
44. Equi A, Balfour-Lynn I, Bush A, Rosenthal M. Long term azithromycin in children with cystic fibrosis: a randomized, placebo-controlled crossover trial. Lancet 2002; 360: 978-984.
45. Payne DNR, Balfour-Lynn IM, Biggart FA, Bush A, Rosenthal M. Subcutaneous terbutaline in children with chronic severe asthma. Pediatr Pulmonol 2002; 33: 356-361.
46. Lex C, Payne D, Wilson NM, Li A, Zacharasiewicz A, Bush A. Is a two week trial of oral prednisolone predictive of target lung function in paediatric asthma? Am J Respir Crit Care Med 2003; 167: A270.
47. Kifle Y, Seng V, Davenport PW. Magnitude estimation of inspiratory resistive loads in children with life-threatening asthma. Am J Respir Crit Care Med 1997; 156: 1530-1535.
48. Salome CM, Reddel HK, Ware SI et al. Effect of budesonide on the perception of induced airway narrowing in subjects with asthma. Am J Respir Crit Care Med 2002; 165: 15-21.
49. Veen JC, Smits HH, Ravensberg AJ, Hiemstra PS, Sterk PJ, Bel EH. Impaired perception of dyspnoea in patients with severe asthma: relation to sputum eosinophils. Am J Respir Crit Care Med 1998; 158: 1134-1141.